India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore.India’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equirus. Strong market performance, soaring ECM activity in pharma, and larger M&A deals are driving the surge, with FY26 fundraising already exceeding Rs 72,440 crore
AU Small Finance Bank Q2 profit jumps 53% to Rs 858 crore
AU’s gross non-performing assets ratio fell 42 basis points (bps) to 1.99% at the end of September. This helped in 25% lower provision at Rs